FDA Raps Lupin for Violations at Indian Facility

Drug Industry Daily
A A
Mumbai-based drugmaker Lupin is in hot water with the FDA over violations at its API and finished-drug plant in Mandideep, Madhya Pradesh.

To View This Article:

Login

Subscribe To Drug Industry Daily